Source: South China Morning PostThe European Medicines Agency has begun a rolling review of China’s Sinovac coronavirus vaccine, the drugs regulator announced on Tuesday.Preliminary data from laboratory studies show that the jab produced an immune response, the EMA said in a press release.The rolling review allows EU regulators to assess data as it becomes available until there is enough evidence to file a formal conditional marketing authorisation application.The EMA did not provide a time frame for its final decision, but…Read More